TESINA FINALE A.A. 2013-14 UNIVERSITA’ GIUSTINO FORTUNATO MILANO ROMA BENEVENTO.
14 15 16 December 2017 Rome - GC Srl Roma · Pulli Raffaele Sassari London Milano Cotignola Firenze...
Transcript of 14 15 16 December 2017 Rome - GC Srl Roma · Pulli Raffaele Sassari London Milano Cotignola Firenze...
14 / 15 / 16 December 2017Rome
President
Nicola MangialardiPierfrancesco Veroux
Sonia RoncheyAlessia GiaquintaMatteo Orrico
Scientific Secretary
G.C. Srl
Organizing Secretary
Salerno AvellinoNancyPadovaPaviaMessina Heidelberg BresciaLeipzigParisCagliariRomaRomaMilanoVareseVareseParisMilanoStanfordCataniaRoma SienaRomaBolognaBordeaux LeipzigNuoroRomaChapel hillCasertaTerniRio De JaneiroTorinoVimercate
Accarino GiancarloAmatucci Giovanni
Amor MaxAntonello Michele
Argenteri AngeloBenedetto Filippo
Böckler Dittmar
Bonardelli StefanoBranzan DanielaBusquet Jacques
Camparini StefanoCao PiergiorgioCapoccia Laura
Cariati MaurizioCarrafiello Gianpaolo
Castelli PatrizioChiche LaurentChiesa Roberto
Dake MichaelD’Arrigo Giuseppe
D’avino Emiliode Donato Gianmarco
De Paulis RuggeroDi Bartolomeo Roberto
Ducasse Eric
Etz ChristianFadda Gianfranco
Fanelli FabrizioFarber Mark
Farina Michele AngeloFerilli Fiore
Ferreira MarceloFerri Michelangelo
Frigerio Dalmazio
FacultyF
AC
UL
TY
list
END
OG
RAFT
Furgiuele SergioGaggiano Andrea
Giaquinta AlessiaGrego Franco
Halliday AlisonHaulon Stephan
Intrieri FrancescoIppoliti Arnaldo
Jannello Antonio MKahlberg AndreaKasprzack Piotr
Kelly PatrickKölbel Tilo
Koskas FabienKuczmik Waclaw
La Barbera GaetanoLachat Mario
Lanza GaetanoLenti Massimo
Lorido AntonioLovato Luigi
Mangialardi NicolaMansour Wassim
Manzi MarcoMarone Enrico M
RomaAstiCataniaPadovaOxford Paris CosenzaRomaVeronaMilanoRegensburg SanfordAmburgoParisKrakowPalermoZurigoCastellanzaPerugiaRomaBolognaRomaRomaAbano TermePavia
FA
CU
LT
Y
list
END
OG
RAFT
Martelli EugenioMastracci Tara
Melissano GermanoMicari Antonio
Michelagnoli StefanoMontorsi Piero
Mosquera A. Nilo JavierMugnai Damiano
Musumeci FrancescoNano Giovanni
Nessi FrancoOderich Gustavo
Orrico MatteoPalasciano Giancarlo
Panneton JeanPecoraro Felice
Peinetti FlavioPerkmann Reinhold
Pestrichella VincenzoPignatelli Francesco
Pogany GabrielePorta Carla
Pratesi CarloPratesi Giovanni
Pulli Raffaele
SassariLondon MilanoCotignolaFirenzeMilanoOurense GeneveRomaMilanoTorinoRochesterRomaSienaNorfolkPalermoAostaBressanoneBariNapoliRomaNovaraFirenzeRomaBari
Reina NicolaRonchey SoniaRossi Michele
Ruffino Maria ARuggeri Massimo
Ruotolo CarloSbarigia Enrico
Scolaro AntonioScuro AlbertoSerena Donato
Setacci CarloSetacci Francesco
Silingardi RobertoSirignano Pasqualino
Smeets Luuk Speziale FrancescoSpinelli Francesco
Stilo FrancescoTalarico Francesco
Taurino MaurizioThulasidasan Narayan
Tinelli GiovanniTorsello Giovanni
Trimarchi SantiTshomba Yamume
Veraldi GianfrancoVeroux Pierfrancesco
Verzini FabioVolpe Pietro
Zamboni Paolo
CaltanissettaRomaRomaTorinoRietiNapoliRomaCataniaVeronaBariSienaMilano ModenaRomaArnhem RomaRomaRomaPalermoRomaLondon RomaMunsterMilanoMilanoVeronaCataniaPerugiaReggio CalabriaFerrara
3.2%Bail- Out Stent Rate *
87.5%1-Year Primary Patency **
UC201802472EE ©2017 Medtronic. All rights reserved.
* DEFINITIVE LE Trial , McKinsey, JACC, 2014
** Freedom from core laboratory-assessed restenosis (duplex ultrasound PSVR ≤2.4) and clinically-driven target lesion revascularization through 12months. Krishnan, VIVA 2016
How do you treat no-stent zones?
WITH A GAIN MAINTAINAPPROACH
MAINTAINVESSEL PATENCY
GAINTHE LUMEN
HawkOne™ Directional Atherectomy System
NOW AVAILABLE IN
6F
IN.PACT™Admiral™ Drug-Coated Balloon
UC201802472EE_B3134med_CV_Interventional_News_Advert_245x342mm.indd 2 09/08/2017 16:45
3.2%Bail- Out Stent Rate *
87.5%1-Year Primary Patency **
UC201802472EE ©2017 Medtronic. All rights reserved.
* DEFINITIVE LE Trial , McKinsey, JACC, 2014
** Freedom from core laboratory-assessed restenosis (duplex ultrasound PSVR ≤2.4) and clinically-driven target lesion revascularization through 12months. Krishnan, VIVA 2016
How do you treat no-stent zones?
WITH A GAIN MAINTAINAPPROACH
MAINTAINVESSEL PATENCY
GAINTHE LUMEN
HawkOne™ Directional Atherectomy System
NOW AVAILABLE IN
6F
IN.PACT™Admiral™ Drug-Coated Balloon
UC201802472EE_B3134med_CV_Interventional_News_Advert_245x342mm.indd 2 09/08/2017 16:45
3.2%Bail- Out Stent Rate *
87.5%1-Year Primary Patency **
UC201802472EE ©2017 Medtronic. All rights reserved.
* DEFINITIVE LE Trial , McKinsey, JACC, 2014
** Freedom from core laboratory-assessed restenosis (duplex ultrasound PSVR ≤2.4) and clinically-driven target lesion revascularization through 12months. Krishnan, VIVA 2016
How do you treat no-stent zones?
WITH A GAIN MAINTAINAPPROACH
MAINTAINVESSEL PATENCY
GAINTHE LUMEN
HawkOne™ Directional Atherectomy System
NOW AVAILABLE IN
6F
IN.PACT™Admiral™ Drug-Coated Balloon
UC201802472EE_B3134med_CV_Interventional_News_Advert_245x342mm.indd 2 09/08/2017 16:45
3.2%Bail- Out Stent Rate *
87.5%1-Year Primary Patency **
UC201802472EE ©2017 Medtronic. All rights reserved.
* DEFINITIVE LE Trial , McKinsey, JACC, 2014
** Freedom from core laboratory-assessed restenosis (duplex ultrasound PSVR ≤2.4) and clinically-driven target lesion revascularization through 12months. Krishnan, VIVA 2016
How do you treat no-stent zones?
WITH A GAIN MAINTAINAPPROACH
MAINTAINVESSEL PATENCY
GAINTHE LUMEN
HawkOne™ Directional Atherectomy System
NOW AVAILABLE IN
6F
IN.PACT™Admiral™ Drug-Coated Balloon
UC201802472EE_B3134med_CV_Interventional_News_Advert_245x342mm.indd 2 09/08/2017 16:45
3.2%Bail- Out Stent Rate *
87.5%1-Year Primary Patency **
UC201802472EE ©2017 Medtronic. All rights reserved.
* DEFINITIVE LE Trial , McKinsey, JACC, 2014
** Freedom from core laboratory-assessed restenosis (duplex ultrasound PSVR ≤2.4) and clinically-driven target lesion revascularization through 12months. Krishnan, VIVA 2016
How do you treat no-stent zones?
WITH A GAIN MAINTAINAPPROACH
MAINTAINVESSEL PATENCY
GAINTHE LUMEN
HawkOne™ Directional Atherectomy System
NOW AVAILABLE IN
6F
IN.PACT™Admiral™ Drug-Coated Balloon
UC201802472EE_B3134med_CV_Interventional_News_Advert_245x342mm.indd 2 09/08/2017 16:45
TOGETHER.IMPROVING LIFE
GORE®, and designs are trademarks of W. L. Gore & Associates. ©2017 W. L. Gore & Associates GmbH AW3109-EN1 MARCH 2017
W. L. Gore & Associates, Inc. • Flagstaff, AZ 86004 • goremedical.com
3.2%Bail- Out Stent Rate *
87.5%1-Year Primary Patency **
UC201802472EE ©2017 Medtronic. All rights reserved.
* DEFINITIVE LE Trial , McKinsey, JACC, 2014
** Freedom from core laboratory-assessed restenosis (duplex ultrasound PSVR ≤2.4) and clinically-driven target lesion revascularization through 12months. Krishnan, VIVA 2016
How do you treat no-stent zones?
WITH A GAIN MAINTAINAPPROACH
MAINTAINVESSEL PATENCY
GAINTHE LUMEN
HawkOne™ Directional Atherectomy System
NOW AVAILABLE IN
6F
IN.PACT™Admiral™ Drug-Coated Balloon
UC201802472EE_B3134med_CV_Interventional_News_Advert_245x342mm.indd 2 09/08/2017 16:45
AF
TE
RN
OO
N
Roo
m -
A
Value and advantages of side branch : when and how side branches are justified M. AntonelloIsolated Branch mid term results : on behalf of the Italian Registry A. GiaquintaLecture: A Look At The Future Of AAA Repair M. Taurino
W. Kuczmick, G. La Barbera, J. Panneton, A. Scuro, D. Serena
Presentations
Panelist
Open repair of pararenal AAA L. ChicheCordis Incraft: from the ordinary EVAR to hostile anatomies repair G. PratesiComplex Chimney Repair in an Emergent Case W. Mansour
Live in The Box
Arch Chimney M. Lachat [Zurich]Heli-Fx Case F. Verzini [Perugia] EVAR with Ovation iX D. Mugnai [Geneva]
Live Cases
L. Lovato, S. Michelagnoli, N. Mosquera, G. Nano, F. Talarico, G. Tinelli
Advanced Endovascular Procedures: adjuncts to ensure durability in hostile anatomies
Moderators
A. Argenteri, D. Frigerio, A. Scolaro
Panelist
TEVAR: Planning & Graft Choice S. RoncheyTips & Tricks for TEVAR S. CampariniTEVAR for TBAD S. TrimarchiAdjuncts for a safe TEVAR: cardiac pacing and TEE E. D’Avino
Presentations
Live CasesArch fenestrated endograft S. Haulon [Paris]GORE®TAG Conformable Thoracic SG with Active Control System D. Böckler [Heidelberg]TEVAR with Relay Plus for TBAD E.M. Marone [Pavia]
M. Ferreira, M. Lenti, F. Nessi, F. Stilo
Moderators
Tevar & beyond
14
Thursday
Thursday
room
room
14:00 / 19:00
14:00 / 19:00
B
ATH
URS
DAY
14TH
AF
TE
RN
OO
N
Roo
m -
B
THU
RSD
AY 1
4TH
Presentations
Live in the box
Live cases
Moderators
12:15
Aortic & iliac stenosis:
G. Carrafiello, M. Farina, G. Lanza, F. Peinetti
Panelist
Popliteal Aneurysm: how to achieve a durable endovascular repair C. PratesiThe evolution of the clinical practice of prostacyclin analogue Iloprost: from alternative hypothesis to concrete adjuvant in Vascular Surgery S. FurgiueleLong-term results of Heparin-Bonded expanded polytetrafluoroethylene stent graft in the treatment of TASC C and D long femoropliteal lesions M.A. Ruffino
A Case For Eluvia N. Mosquera Stem cells & CLI : Top to toe F. Peinetti
Complex Femoro Popliteal – A case for Supera M. Manzi [Abano Terme] Complex BTK revascularization A. Micari [Catania]Debullking & filter case S. Ronchey [Rome]
S. Furgiuele, F. Koskas, G. Palasciano, F. Pignatelli, G. Pogany
News on PAD
Joint Session with Endovascular Master Class 2.0 Live CHEVAR from Munster Special Panelist: G. Torsello
Live cases
Live in the box
PanelistJ. Busquet, P. Castelli, C.M. Porta, N. Reina
Endovascular treatment of Aorto-iliac Juxtarenal Occlusion: challenges & advantages G. FaddaCERAB technique: updates on techinque & material L. Smeets
Presentations
Transfemoral TAVI F. Musumeci [Rome]Aortoiliac recanalization S. Ronchey [Rome]
CERAB technique for heavily stenosed aortoiliac bifurcation L. Smeets
R. Di Bartolomeo, N. Mosquera, L. Smeets, G. Veraldi
Moderators
Friday room09:00 / 13:00
14:00 / 19:00
AFRID
AY 15TH
MO
RN
IN
G
Room
- A
FRIDAY 15
TH
AF
TE
RN
OO
N
Room
- A
15
Value and advantages of side branch : when and how side branches are justified M. AntonelloIsolated Branch mid term results : on behalf of the Italian Registry A. GiaquintaLecture: A Look At The Future Of AAA Repair M. Taurino
W. Kuczmick, G. La Barbera, J. Panneton, A. Scuro, D. Serena
AF
TE
RN
OO
N
Moderators
Moderators
Panelist
G. Amatucci, F. Intrieri, A.M. Jannello, A. Kahlberg, A. Lorido, E. Sbarigia
FEVAR & BEVAR: Materials & strategy choice T. MastracciCreative Strategies for treating Post Dissective Thoracoabdominal Patients M. FerreiraTips and tricks to manage difficulties during FEVAR & BEVAR T. MastracciPercutaneous axillary artery access for the endovascular treatment of TAAAs D. BranzanIVUS guidance to gain collapsed true lumen in a complicated acute type-B dissection P. Veroux
Presentations
Thoracoabdominal Repair with Gore TAMBE M. FarberRecorded Live Case – BEVAR in a post-dissective aneurysm P. Kasprzak /K.OikonomouFEVAR with preloaded grafts in TBAD G. Oderich
Live in the box
Dissection False Lumen Treatment T. Kölbel [Hamburg]T-Branch R. Silingardi [Reggio Emilia]
Live casesM. Cariati, A. Gaggiano, G. Melissano, P. Volpe
Frontiers in Thoracoabdominal pathology I
12:15 Joint Session with Endovascular Master Class 2.0: Live ChEVAR from Munster Special Panelist: G. Torsello
F. Ferilli, A. Halliday, M. Rossi, M. Ruggeri, F. Spinelli
Panelist
How do I make plaque stenting a safe procedure G. de DonatoHow do I plan access to carotid lesion F. SpezialeHow stent choice was modified along the ACST studies A. Halliday0 gravity cerebral flow P. Zamboni
Presentations
Stenting with GCS M. FerriDon’t Forget CEA – 3D recorded case C. PratesiStenting for obstructive disease of central veins G. D’ArrigoMechanical Thromboaspiration with AngioJet N. Thulasidasan
Live casesRoadsaver Stenting with proximal protection device C.Setacci [Catania]Double distal protection device for soft plaque M. Amor [Nancy] A case for C-Guard P.Montorsi [Catania]
G. Accarino, M.Dake, F. Fanelli, R. Perkmann
MO
RN
IN
G
Roo
m -
B
FRID
AY 1
5THFR
IDAY
15TH
AF
TE
RN
OO
N
Roo
m -
B
Live in the box
News on Carotids & Veins
15Friday room09:00 / 13:00
14:00 / 19:00
B
SATURD
AY 16TH
MO
RN
IN
G
Room
- A
FEVAR for dissections: tips, tricks & lessons learned T. MastracciParaplegia Prevention in TAA open & endo reapair G. MelissanoMISACE technique for paraplegia prevention C. EtzLecture : Frontiers in Vascular Surgery M. Dake
3D recorded case - recorded thoracoabdominal open case R. ChiesaRecorded endo - debranch with new Valiant TAAA A. Kelly
Frontiers in Thoracoabdominal pathology II MO
RN
IN
G
How do I make plaque stenting a safe procedure G. de DonatoHow do I plan access to carotid lesion F. SpezialeHow stent choice was modified along the ACST studies A. Halliday0 gravity cerebral flow P. Zamboni
Room
- BM
OR
NI
NG
Evolution of Endovascular Arch repair P. CaoTransapical Access is a valid alternative in patients with severe iliac stenosis F. GregoVORTEC Technique F. Setacci
F. Benedetto, E. Martelli, M. Ruggeri, F Setacci, P. Sirignano
Presentations
Panelist
Iliac branch with Jotec/ the swiss way M. Lachat Iliac Branch with Jotec/the italian way S. Michelagnoli Open Chimney E. Ducasse
Live In The Box
ChEVAS M. Ferri [Torino]New generation AFX withouth contrast medium P. Veroux [Catania]
Live Cases
S. Bonardelli, P. Cao, A. Ippoliti, C. Ruotolo
Moderators
Solutions For Complex Thoracic & Abdominal Repair
Presentations
L. Capoccia, A. Kahlberg, A. Kelly, V. Pestrichella, Y. Tshomba
Panelist
FEVAR with Cook-FEN P. Kasprzak / K. Pfister [Regensburg]FEVAR with Anaconda S. Ronchey [Rome]
Live Cases
Live in the box
R. Chiesa, R. De Paulis, M. Lachat, C Pratesi, R. Pulli, M. Taurino
Moderators
SATURD
AY 16TH
Saturday
Saturday
room
room
09:00 / 16:00
09:00 / 16:00
A
B
16
Our unique design allows a tailored fitMore opportunities to treat your patient’s individual anatomyVascutek provides a Case Rehearsal Service which allows clinicians to confirm the approach and procedural plan, giving them total confidence during implantation and contributing to our 99% target vessel cannulation rate
100% procedure technical success rate
Case Rehearsal Service with prototype testing
3 weeks delivery time
Custom Made Devices available subject to local regulatory guidelines. Caution – not available in the USA.
VASCUTEK LtdNewmains Avenue, Inchinnan
Renfrewshire PA4 9RR, ScotlandTel. +44 (0) 141 812 5555
@vascutek | www.vascutek.com
References available on request.
Distribuito da:Serom Medical Technology SrlVia Atimeto, 40 - 00178 ROMATel: 06718 2448 Fax: 06718 6721e-mail. [email protected]
MO
RN
IN
G
Parallel session for Radiographers & Nurse
Radiation ProtectionThe Hybrid Room And The Golden RulesIstisan Report 41/15
La sala ibrida e le regole d’oroRapporto istisan 41/15
Moderators
C. Ciaralli
S. Panci- C.Varchetta- A. Di Lascio
S. Panci- C.Varchetta- A. Di Lascio
Friday room10:00 / 16:30
10:30 / 11:30
C
Management and organization model of the multidisciplinary team in the hybrid room La Gestione del Blocco Operatorio: complessità e criticità C. Scherillo La Sala Ibrida S. Brogi
15:30 / 16:30
ENDOGRAFT & AITRI AWARD FOR RADIOGRAPHERSThe Best Thesis of the year
Miglior tesi 2017
F.Santarelli-P.Cornacchione-S.Caprasecca-D.Pasini-R.Monaco
10:00 / 11:30
MO
RN
IN
G
Roo
m -
CR
oom
- C
FRID
AY 1
5THSA
TURD
AY 1
6TH15
16The Zenith Alpha™ Endovascular System consists of:Zenith Alpha Thoracic Endovascular GraftZenith Alpha Abdominal Endovascular GraftZenith Alpha Spiral-Z® Endovascular Leg
Can also include:Zenith® Branch Endovascular Graft – Iliac Bifurcation
© COOK 11/2017 AI-D39682-EN-F
Designed to help you deliver a durable repair.
Zenith Alpha™
E N D O VA S C U L A R S Y S T E M
cookmedical.eu
Some products or part numbers may not be available in all markets. Contact your local Cook representative or Customer Service for details.
Learn more at: cookmedical.eu/aortic-intervention
The Zenith Alpha™ Endovascular System consists of:Zenith Alpha Thoracic Endovascular GraftZenith Alpha Abdominal Endovascular GraftZenith Alpha Spiral-Z® Endovascular Leg
Can also include:Zenith® Branch Endovascular Graft – Iliac Bifurcation
© COOK 11/2017 AI-D39682-EN-F
Designed to help you deliver a durable repair.
Zenith Alpha™
E N D O VA S C U L A R S Y S T E M
cookmedical.eu
Some products or part numbers may not be available in all markets. Contact your local Cook representative or Customer Service for details.
Learn more at: cookmedical.eu/aortic-interventionThe Zenith Alpha™ Endovascular System consists of:
Zenith Alpha Thoracic Endovascular GraftZenith Alpha Abdominal Endovascular GraftZenith Alpha Spiral-Z® Endovascular Leg
Can also include:Zenith® Branch Endovascular Graft – Iliac Bifurcation
© COOK 11/2017 AI-D39682-EN-F
Designed to help you deliver a durable repair.
Zenith Alpha™
E N D O VA S C U L A R SY S T E M
cookmedical.eu
Some products or part numbers may not be available in all markets. Contact your local Cook representative or Customer Service for details.
Learn more at: cookmedical.eu/aortic-intervention
Low Profile, Yet Durable
1. Torsello G, Brunkwall J, Scheinert D. Cordis INCRAFT™ ultra-low profile AAA Stent-Graft System. J Cardiovasc Surg (Torino). 2011;52(5):661-667.2. Innovation 5-year results. Torsello G. LINC, 2017.For Healthcare Professionals only. The use of the INCRAFT® AAA Stent-Graft System requires that physicians be specially trained in endovascular abdominal aortic aneurysm repair techniques, including experience with high resolution fluoroscopy and radiation safety. Cordis Corporation will provide training specific to the INCRAFT® AAA Stent-Graft System. CORDIS, Cordis LOGO, and INCRAFT are trademarks or registered trademarks of Cardinal Health. Prior to use, refer to the Instructions for Use supplied with this device for indications, contraindications, side effects, suggested procedure, warnings, and precautions. As part of the Cordis policy of continuous product development, we reserve the right to change product specifications without prior notification. © 2017 Cardinal Health. All rights reserved. EU2141 03/17
DURABLE1,2ULTRA-LOW
PROFILE
CLINICALLY PROVEN
INNOVATION 5-year results demonstrate INCRAFT® AAA Stent Graft System clinical efficacy and durability:
FREEDOM from migrations through 5Y follow-up
FREEDOM from AAA related MAEs through 5Y follow-up
FREEDOM from Type Ia and III endoleaks at 5Y follow-up
FREEDOM from occlusions and fractures through 5Y follow-up
FREEDOM from Type Ib at 5Y follow-up
97,4%
97,4%
100%
100%
100%
Low Profile, Yet Durable
1. Torsello G, Brunkwall J, Scheinert D. Cordis INCRAFT™ ultra-low profile AAA Stent-Graft System. J Cardiovasc Surg (Torino). 2011;52(5):661-667.2. Innovation 5-year results. Torsello G. LINC, 2017.For Healthcare Professionals only. The use of the INCRAFT® AAA Stent-Graft System requires that physicians be specially trained in endovascular abdominal aortic aneurysm repair techniques, including experience with high resolution fluoroscopy and radiation safety. Cordis Corporation will provide training specific to the INCRAFT® AAA Stent-Graft System. CORDIS, Cordis LOGO, and INCRAFT are trademarks or registered trademarks of Cardinal Health. Prior to use, refer to the Instructions for Use supplied with this device for indications, contraindications, side effects, suggested procedure, warnings, and precautions. As part of the Cordis policy of continuous product development, we reserve the right to change product specifications without prior notification. © 2017 Cardinal Health. All rights reserved. EU2141 03/17
DURABLE1,2ULTRA-LOW
PROFILE
CLINICALLY PROVEN
INNOVATION 5-year results demonstrate INCRAFT® AAA Stent Graft System clinical efficacy and durability:
FREEDOM from migrations through 5Y follow-up
FREEDOM from AAA related MAEs through 5Y follow-up
FREEDOM from Type Ia and III endoleaks at 5Y follow-up
FREEDOM from occlusions and fractures through 5Y follow-up
FREEDOM from Type Ib at 5Y follow-up
97,4%
97,4%
100%
100%
100%
VIOLATECH S.R.LVia Durban, 4 • 00144 Roma
Tel. +39 065922087 • Fax: +39 [email protected] • www.violatech.it
TECNOLOGIE E SERVIZI BIOMEDICALI
Congress Venue:Roma Eventi Fontana di TreviPiazza della Pilotta, 400187 Roma Tel 06.67015177
Organizing SECRETARIAT:G.C. SRLVIA DELLA CAMILLUCCIA, 535 00135 ROMATEL 06 85305059Email: [email protected]
REGISTRATION:Registration at the congress must be requested by mail to: [email protected] registration is free.
SECRETARY IN CONGRESSThe Organizing Secretariat at the congress will open half an hour before the start of the scientific program and close half an hour after the end of the scientific program, throughout the congress period.
TECHNICAL EXHIBITION:Technical exhibition will be in parallel with the scientific program.
BADGEEvery regularly registered participant will receive a badge at the time of registration, which will allow him access to congress rooms. The staff will control the possession.
CERTIFICATE OF PARTICIPATIONParticipation certificate will be issued on the last day of the congress personally to all regi-stered participants who will request it to the Secretariat on site.
SLIDES CENTERYou will not be able to connect your personal laptops directly to the projector.
For a smooth running of the sessions, the Speakers are kindly invited to present themselves
at the Slide Center and deliver the presentations at least 1 hour before the beginning of their
session or the previous afternoon for the morning sessions.
Presentations must be prepared in Power Point (.ppt) format using Microsoft Power Point
Office Package and will have to be saved on a USB stick (pendrive).
GENERAL INFORMATIONS
ENDOvascular Global Roman Aortic Featured TherapiesRoma, 14-16 Dicembre 2017
Centro Eventi Fontana di Trevi
1 2 3
4 5 6 7
SALA
B
CENTROSLIDE
SALA D
SALA E
9
10
8
11
12
13 14
SALA C
15 16
17
1bis
COFFEE STATION
CO
FFEE STATIO
N
SEGRETERIA
AUDITORIUM
GU
ARD
AR
OB
A4bis
Plane
ST
AN
D
list
END
OG
RAFT
ABBOTTAB MEDICA + OFFICINE RIZZOLI
ASSUT EUROPEBIO VASCULAR
CARDINAL HEALTH / CORDISCOOK MEDICAL
CROSSMEDENDOLOGIX
JOTECMEDTRONIC ITALIA
SEROM MEDICAL TECHNOLOGYTERUMO ITALIA
WL GORE
3 4bis 1bis 4 81+217 15+16 7 13+14 9+10 5+6 11+12
Sponsor Stand
®
®
A Penumbra Company
PATROCINI RICHIESTI
PATROCINI RICHIESTI Notes
www.gc-conor.it